Predicting outcomes in HIV-infected veterans: II. Survival after AIDS

Journal of Clinical Epidemiology

Volumn 50, Issue 11, 1997, Pages 1241-1248

  Rabeneck, Linda ^a,c   Hartigan, Pamela M ^b   Huang, Iris W ^a   Souchek, Julianne ^a   Wray, Nelda P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Dept Vet Aff Coop Studs Prog ^*  (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome; HIV; Prognosis; Severity of illness index

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL COUNT; DISEASE ACTIVITY; FEMALE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONSET AGE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STAGING; SURVIVAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MARKOV CHAINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; VETERANS; ZIDOVUDINE;

EID: 0030853228     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(97)00182-0     Document Type: Article

References (31)

1. Chang HH, Morse DL, Noonan C, et al. Survival and mortality patterns of an acquired immunodeficiency syndrome (AIDS) cohort in New York state. Am J Epidemiol 1993; 138: 341-349.
2. Osmond D, Charlebois E, Lang W, et al. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA 1994; 271: 1083-1087.
3. Rabeneck L, Hartigan PM, Huang IW, Souchek J, Wray NP. Predicting outcomes in HIV-infected veterans: I. Progression to AIDS. J Clin Epidemiol 1997; 50(11): 1231-1240.
4. Feinstein AR. Clinical biostatistics. XIV. The purposes of prognostic stratification. Clin Pharmacol Ther 1972; 13: 285-297.
5. Feinstein AR. Clinical Epidemiology. The Architecture of Clinical Research. Philadelphia: WB Saunders; 1985.
6. Saah AJ, Hoover DR, He Y, et al. Factors influencing survival after AIDS: Report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr 1994; 7: 287-295.
7. Justice AC, Feinstein AR, Wells CK. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med 1989; 320: 1388-1393.
8. Justice AC, Aiken LH, Smith HL, Turner BJ. The role of functional status in predicting inpatient mortality with AIDS: A comparison with current predictors. J Clin Epidemiol 1996; 49: 193-201.
9. Turner BJ, Markson LE, McKee L, Houchens R, Fanning T. The AIDS-defining diagnosis and subsequent complications: A survival-based severity index. J Acquir Immune Defic Syndr 1991; 4: 1059-1071.
10. Turner BJ, Markson L, Taroni F. Estimation of survival after AIDS diagnosis: CD4 T lymphocyte count versus clinical severity. J Clin Epidemiol 1996; 49: 59-65.
11. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36: 1-15S.
12. Hamilton JD, Hartigan PM, Simberkoff MS, et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. N Engl J Med 1992; 326: 437-443.
13. Simberkoff MS, Hartigan PM, Hamilton JD, et al. Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment: Report of a Veterans Affairs Cooperative Study. J Acquir Immune Defic Syndr 1996; 11: 142-150.
14. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41(RR-17): 1-19.
15. Hessol NA, Koblin BA, van Griensven GJP, et al. Progression of human immunodeficiency virus Type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol 1994; 139: 1077-1087.
16. Colford JM, Ngo L, Tager I. Factors associated with survival in human immunodeficiency virus-infected patients with very low CD4 counts. Am J Epidemiol 1994; 139: 206-218.
17. Steinberg JP, Spear JB, Murphy RL, et al. Predictors of outcome in AIDS patients receiving zidovudine. J Acquir Immune Defic Syndr 1989; 2: 229-234.
18. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc (B) 1972; 34: 187-220.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-481.
20. Efron B. The Jackknife, the Bootstrap and Other Resampling Plans. Philadelphia: SIAM; 1982.
21. Chiang CL. An Introduction to Stochastic Processes and Their Applications, 2nd Edition. New York: Krieger; 1980.
22. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, Ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949: 191-205.
23. Stone VE, Seage GR, Hertz T, et al. The relation between hospital experience and mortality for patients with AIDS. JAMA 1992; 268: 2655-2661.
24. Mocroft AJ, Johnson MA, Sabin CA, et al. Staging system for clinical AIDS patients. Lancet 1995; 346: 12-17.
25. Weingarten S, Bolus R, Riedinger MS, et al. The principle of parsimony: Glasgow coma scale score predicts mortality as well as the APACHE II score for stroke patients. Stroke 1990; 21: 1280-1282.
26. Longini IM, Clark WS, Byers RH, et al. Statistical analysis of the stages of HIV infection using a Markov model. Stat Med 1989; 8: 831-843.
27. Longini IM, Clark WS, Karon JM. Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort. Am J Epidemiol 1993; 137: 1229-1240.
28. Centers for Disease Control and Prevention. Update: Trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR 1997; 46: 165-173.
29. CDC. HIV/AIDS Surveillance Report. Atlanta: US Department of Health and Human Services, Public Health Service 1996; 8: 1-33.
30. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996: Recommendations of an international panel. JAMA 1996; 276: 146-154.
31. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167-1170.